These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 5308753

  • 1. [Control of cholesterol and blood triglycerides with ethyl-p-chlorophenoxyisobutyrate (CPIB)].
    Vaissman I, Kamel D, Fraga Filho C.
    Hospital (Rio J); 1968 May; 73(5):1477-82. PubMed ID: 5308753
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of parachlorophenoxyisobutyric acid (CPIB acid) and of diet on blood cholesterol and on the beta-alpha lipoprotein ratio in aged subjects].
    Bronzini A, Di Gregorio D, Scotti G.
    G Gerontol; 1969 Nov; 17(11):1067-75. PubMed ID: 5397791
    [No Abstract] [Full Text] [Related]

  • 3. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM, Attia O, Nabih AE, Nassar I, Ibrahim WN.
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract] [Full Text] [Related]

  • 4. [Regression of the lipoidic corneal arch. Experience with CPIB (ethyl chlorophenoxyisobuyrate). Preliminary report].
    Wolosker M.
    Hospital (Rio J); 1969 Jun; 75(6):2131-3. PubMed ID: 5311470
    [No Abstract] [Full Text] [Related]

  • 5. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N.
    Acta Med Scand; 1970 Mar 03; 187(3):213-8. PubMed ID: 5444978
    [No Abstract] [Full Text] [Related]

  • 6. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
    De Gennes JL, Maunand B, Salmon D, Laudat P, Truffert J.
    Rev Atheroscler (Paris); 1966 Mar 03; 8(1):27-52. PubMed ID: 5961027
    [No Abstract] [Full Text] [Related]

  • 7. [Action of ethyl chlorophenoxyisobutyrate (CPIB) on blood lipids].
    Giannini SD, da Silva WN, Luthold WW, Coelho LT, Bitelli T.
    Rev Bras Med; 1965 Nov 03; 22(11):702-7. PubMed ID: 5892979
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H, Jaillard J.
    Lille Med; 1968 Jan 03; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract] [Full Text] [Related]

  • 9. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L, Rétsági G, Sebestyén M, Diczendy S, Erdélyi G.
    Z Gesamte Inn Med; 1966 Mar 15; 21(6):169-72. PubMed ID: 5988081
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of a phenolic ether, Su-13437, on serum cholesterol, triglyceride, and transaminase levels of human subjects.
    Duncan CH, Best MM.
    Circulation; 1970 Nov 15; 42(5):859-65. PubMed ID: 5477258
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Therapeutic trial of simvastatin versus fenofibrate in primary hypercholesterolemia].
    Turki S, Mekaouer A, Kaabachi A, Ftouhi B, Mebazaa R, Ben Khalifa F.
    Tunis Med; 1994 Nov 15; 72(11):619-24. PubMed ID: 7762089
    [No Abstract] [Full Text] [Related]

  • 15. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A, Rodset JM.
    Acta Med Scand; 1971 May 15; 189(5):385-9. PubMed ID: 5578488
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
    Vannas S, Esilä R, Tuovinen E.
    Acta Ophthalmol (Copenh); 1968 May 15; 46(2):162-70. PubMed ID: 5755673
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The efficacy and safety of fluvastatin in hypercholesterolemia in renal transplant recipients.
    Ghods AJ, Milanian I, Arghani H, Ghadiri G.
    Transplant Proc; 1995 Oct 15; 27(5):2579-80. PubMed ID: 7482835
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.